Reason for request
Inclusion
Clinical Benefit
| Insufficient |
The actual benefit of CLIMASTON 0.5 mg/2.5 mg is insufficient for reimbursement by National Health Insurance in the Marketing Authorisation indication. |
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
2qDp2TbtTUbbyCan
Listen
